FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognise and kill cancer cells. The therapy initially called CAR-T cell immunotherapy and now named Kymriah by Novartis, is approved to treat children and young adults with a recurrent form of the blood cancer called acute lymphoblastic leukemia (ALL). Dr. Carl June of University of Pennsylvania is one of the pioneers of CAR-T cell research and leads the team responsible for the historic FDA approval. We are discussing Dr. June's CAR-T cell journey to understand the nuances of this new therapy. The discussion will also bring to focus the opportunity that these engineered immune cells present to cancer treatment, and their possible use in treatment of other cancers.
Dr. Carl June
Demystifying Stem Cell Transplants for Multiple Myeloma Treatment with Dr. Rafael Fonseca
In 2017 stem cell transplants remains a key option for treatment of eligible multiple myeloma patients, and in majority pf patients its is done as a part of frontline therapy. Research shows that stem cell transplants significantly increase the amount of time, for which a patient has their disease under control. How safe are these transplants? Who is eligible to get one? What are the side effects and how can patients tackle them? The myeloma panel is talking to Dr. Rafael Fonseca for answers to these and more on the latest developments in stem cell transplant technology in multiple myeloma.
Dr. Rafael Fonseca
CureTalks Webinar: Climbing Mount Kilimanjaro for the Multiple Myeloma Research Foundationwith Matt Goldman
In February 2017, along with 5 other patients and 10 individuals who have had their lives impacted by myeloma, Matt Goldman climbed Mt. Kilimanjaro in Tanzania, Africa. They were raising funds for multiple myeloma research foundation (MMRF), which is a leading organisation working to find myeloma cure. Kilimanjaro is 19,000 feet high. The journey took 8 days where they covered over 40 miles. Join us to hear Matt re-live his experience.
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!